Mitsubishi UFJ Asset Management (UK) Ltd. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management (UK) Ltd. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$662
-35.2%
24,000
-29.4%
0.47%
-29.1%
Q2 2023$1,022
-11.8%
34,000
+6.2%
0.66%
-12.4%
Q1 2023$1,159
-24.4%
32,000
-25.6%
0.75%
-30.0%
Q4 2022$1,534
-99.9%
43,0000.0%1.07%
-4.7%
Q3 2022$1,456,000
+17.0%
43,0000.0%1.12%
+56.3%
Q2 2022$1,244,000
-99.9%
43,0000.0%0.72%
+14.9%
Q1 2022$1,389,760,000
+110726.2%
43,0000.0%0.63%
+17.0%
Q4 2021$1,254,000
+34.4%
43,000
+22.9%
0.54%
+35.8%
Q3 2021$933,000
+25.2%
35,000
+55.6%
0.39%
+4277.8%
Q2 2019$745,000
-22.7%
22,500
-18.2%
0.01%
-30.8%
Q1 2019$964,000
+5.5%
27,5000.0%0.01%
-97.2%
Q4 2018$914,000
+3.7%
27,500
+57.1%
0.46%
+1740.0%
Q3 2018$881,000
+9.2%
17,500
+29.6%
0.02%
-94.5%
Q2 2018$807,000
+30.6%
13,5000.0%0.46%
+9.9%
Q1 2018$618,000
-53.7%
13,500
-59.7%
0.41%
-56.9%
Q4 2017$1,334,00033,5000.96%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders